Chase Beisel
About Chase Beisel
Chase Beisel is a Co-Founder and Advisor with extensive experience in RNA-based infection research and synthetic biology. He currently serves as a Full Professor and Head of Department at the Helmholtz Institute for RNA-based Infection Research in Germany.
Work at Locus Biosciences
Chase Beisel serves as a Co-founder and Advisor at Locus Biosciences, Inc. since 2015. In this role, he contributes to the strategic direction and scientific advancements of the company. Locus Biosciences focuses on developing innovative solutions in the field of biotechnology, particularly in the area of RNA-based therapies.
Education and Expertise
Chase Beisel earned a Bachelor of Science in Chemical Engineering from Iowa State University, completing his studies from 2000 to 2004. He furthered his education at Caltech, where he obtained a PhD in Chemical Engineering from 2004 to 2009. His academic background provides a strong foundation for his expertise in RNA biology, synthetic biology, and systems biology techniques.
Background
Chase Beisel's professional background includes significant academic and research positions. He worked as an Associate Professor at North Carolina State University from 2017 to 2022 and held a postdoctoral fellowship at the National Institutes of Health from 2009 to 2011. He is currently a Full Professor and Head of Department at the Helmholtz Institute for RNA-based Infection Research in Würzburg, Germany, since 2021.
Achievements
Throughout his career, Chase Beisel has been involved in various research initiatives, particularly in molecular biology techniques and RNA-based infection research. His work has contributed to advancements in both mammalian and bacterial cell culture methodologies. He has also held leadership roles, including serving as a member of the Scientific Advisory Board at Benson Hill since 2019.
Current Positions
In addition to his role at Locus Biosciences, Chase Beisel is currently the Co-founder and Chief Scientific Officer at Leopard Biosciences, a position he has held since 2023. He also serves as a member of the Scientific Advisory Board at Benson Hill, contributing to the company's scientific direction and innovation efforts.